The Role of NMR and Mass Spectroscopy in Glycan Analysis
NMR analysis provides crucial structural information of synthesized glycans while LC-MS/MS is ideal for quantitation of free sugars in biological matrices.

Early Communication with Regulators is Essential for SMEs
With SMEs gaining wider recognition as the powerhouse of research and innovation in Europe, regulatory agencies are urging companies to engage with regulators early in the drug-development process.

Calibration of instruments: Is Your UV Spectrometer Accurate Enough?
This article takes a statistical look at the calibration requirements for a UV spectrometer.

Innovation on the Rise among Indian Pharmaceutical Companies
Known for generic drug development, Indian pharmaceutical companies have increased innovation over the past few years.

Teva to Expand Central Nervous System Portfolio with Acquisition of NuPathe
Teva announced an agreement to acquire NuPathe and its migraine treatment patch.

EMA Recommended 81 Medicines for Marketing Authorization in 2013
In 2013, the EMA's Committee for Medicinal Products for Human Use recommended 81 medicines for human use for marketing authorization, compared with 57 in 2012.

Shire Appoints Susan Kilsby as Its New Chairman Effective April 2014
Shire appoints Susan Kilsby as its New Chairman.

FDA Prohibits Another Ranbaxy Facility from Producing Drugs for US Market
FDA adds Ranbaxy’s Toansa, India facility to existing consent decree, prohibiting distribution of APIs from that location.

Novo Nordisk Launches New Insulin Injection Device in US
NovePen Echo is the first insulin injection device combining half-unit dosing and memory function.

Catalent Applied Drug Delivery Institute Partners with AAPS on 3rd Annual Global Academic Competition
Competition seeks to encourage academic research and accelerate drug delivery applications.

Copley Scientific Launches Two New Products for MDI Testing
Products enable testing in accordance with methods described in new USP monograph.

Highlights from EMA's CHMP January 2014 Meeting
The Committee for Medicinal Products for Human Use (CHMP) held a meeting on Jan. 20-23, 2014.

Novozymes Biopharma's Technology Demonstrates Potential for Monthly Drug Dosing
Novozymes Biopharma has released new study data on extending the serum half-life of albumin in vivo.